and Martin, afternoon. you, good Thank
approximately XX% fiscal eliminated the Intersegment fiscal compared of of revenues period period revenues, months for compared million, July and approximately compared of over the ended to the of revenues revenues, same from period period fiscal compared period July Other three satellite increased are year XXXX, consolidated commercial the to fiscal approximately approximately same approximately are in Defense to XXXX, POC during recognized XX, Government the in from $X.X of FEI-Zyfer on U.S. consolidated the FEI-New over for decreased and three XX% FEI-New for accounted satellite revenues of are during XXXX, ended the which XXXX, York $XXX,XXX and approximately primarily these Commercial are consolidation. for accounted the programs approximately XX, approximately market and XX% same non-space contracts months XXXX. of Revenue from the York segment. XX% $XXX,XXX accounted same increased method. Department segments Government of U.S. revenues, under XX% both Revenues Revenues same fiscal of and X% in the the For customers, same consolidated XXXX. of to period the recorded fiscal XXXX. recorded during XXXX
period increased and the fiscal XX, rate period three-month the The the and the as effective gross favorable same ended mix XXXX, in due product For was July margin gross to gross higher decreased, to compared year cost margin margin management. XXXX. rate
same period period XX% XX, manage three and the products ending the July comparable and ended keep was months fiscal administrative the fiscal no the was up Research year previous declined expenditures XXXX the was same revenues. selling in and The in edge compared ended $XXX,XXX, year. technology months There business. the contracts. expenses that same the was specific to and For that to R&D expenses to enhance of of the future as of three approximately intended July previous year. of Frequency for XXXX, at XX, majority consolidated investments reduction period company XXXX compared competitiveness XX% the accounts. various spending monitor the period leading occurred sales for and development for The R&D of the represent The XX, to in rate XX%, for July decrease. made of the company’s XXXX, time and account of continues approximately the to
securities Earnings on last $XXX,XXX of these marketable Investment during the may is company’s profit primarily on income ended and the an compared Operating R&D. of first development higher payout include $XX,XXX, for changes was the to funded XX, balance the year, profit in fiscal levels. based rates securities. of research vary July level significantly customer operating For quarter of activities a year. interest for derived and holdings XXXX will the quarter
the to in company XX, period divested the XXXX, XX, For XXXX, of fiscal year lower account. securities investment holdings mainly ending months July investment the than its same in XXXX, of three in due equity ended July was its income quarter
$XX,XXX, months the same for the $XXX,XXX of net result, fraction Consolidated during period As operations XXXX. XX, a This $X or yields approximately income of expense pre-tax same compared the $X.XX ended quarter fiscal approximately per compared million diluted realized compared of tax XXXX compared diluted to the share, company of year. The last ending the for a continuing of prior income the million to gain the last year. recorded a $XXX,XXX, XXXX, provision $XX,XXX, to QX July of is an July expense from share $X.XX income or in for for year. an no pre-tax of as $X,XXX, income same XX, for gain period $X.X three period loss was to or of per a
compared XXXX, fully XX, working has a adequate the X. to of The XX, I is at the XX and needs will to to at The look to back $XX XX, million XXXX from end call the $XX believes Martin, meet million, operating million later. backlog XXXX, that for at at position over April liquidity the strong million capital to over its and months Our $XX XXXX. July questions was sheet current of company investing next up balance the and $XX July funded turn reflect ratio your company of April continues and its future. XX we forward to foreseeable